-
Mashup Score: 1
DealForma’s Chris Dokomajilar has been running the numbers again and backs up some of the things we were already pretty sure about — while raising new questions about just how deep and lasting this biotech recovery can be. At the top of the list of Q1 trends: PIPEs are brimming, follow-ons
Source: endpts.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 9
In recent weeks, proposed federal legislation has forced US drugmakers to rethink their relationship with a Chinese company that’s a staple in drug development. Now, the industry is starting to wake up to the potential for restrictions on additional Chinese biotech contractors. The Biosecure Act threatens to blacklist WuXi AppTec
Source: endpts.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Investors Flock Back to Biotech After a Long, Cold Spell - 1 month(s) ago
Among the startups pulling in cash are companies chasing hot research areas such as cancer and weight loss.
Source: www.wsj.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 5Early-stage oncology startup Boundless Bio files for IPO - 1 month(s) ago
Boundless Bio has filed to go public as it approaches early safety and efficacy data for its first clinical attempt at a unique take on treating cancer. The five-year-old San Diego startup revealed its plans Wednesday to trade on the Nasdaq as “BOLD.” The move comes as investor sentiment picks
Source: endpts.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Gene Therapy Allows an 11-Year-Old Boy to Hear for the First Time - 3 month(s) ago
The genetic treatment targeted a particular kind of congenital deafness and will soon be tried in children who are younger.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7
During our lives, normal exposures cause DNA damage to build up. Eventually, this causes cancer and age-related diseases. Studying DNA-repairing animals could help treat these issues.
Source: www.dailymail.co.ukCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 13 trends to watch in biotech in 2024 - 4 month(s) ago
After two years of steady decline in biotech, industry optimists might be onto something heading into 2024.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4Top 25 Biotech Companies of 2023 - 4 month(s) ago
This A-List presents GEN’s updated list of the top 25 biotech companies, ranked by their market capitalization as of May 2, 2023.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 4Top 25 Biotech Companies of 2023 - 4 month(s) ago
This A-List presents GEN’s updated list of the top 25 biotech companies, ranked by their market capitalization as of May 2, 2023.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 13 trends to watch in biotech in 2024 - 4 month(s) ago
After two years of steady decline in biotech, industry optimists might be onto something heading into 2024.
Source: www.statnews.comCategories: General Medicine News, General HCPsTweet
Let's shift gears. There's good news and bad news in our Q1 #biotech reports today. Not surprising that a scan of the numbers highlights opportunity and concern. Thanks again to @ChrisDoko at DealForma for running the number. https://t.co/oIG4PO8ukk